BLAINTRAMUSCULARINJECTION, SUSPENSION1 Generic Approved
Approved
Aug 2025
Lifecycle
Launch
Competitive Pressure
30/100
Clinical Trials
3
Data completeness
2/8 — Basic
Drug data last refreshed 10h ago · AI intelligence enriched 5d ago
AI summarySynthesized from FDA + DailyMed + ClinicalTrials.gov data
Spikevax is an mRNA-based COVID-19 vaccine developed by Moderna that encodes instructions for cells to produce the spike protein of SARS-CoV-2, triggering an immune response. Administered via intramuscular injection, it is indicated for prevention of COVID-19 disease across eligible populations. The vaccine represents a first-in-class mRNA platform technology now established as a cornerstone of pandemic preparedness.
Launch
Recently approved vaccine entering market at Launch phase with 185 linked roles, signaling active team expansion and sustained commercial investment.
Mechanism of Action
Mechanism of action data is being enriched from DailyMed and FDA sources. Check back soon for updated drug intelligence.
Indications
Indication data is being enriched from DailyMed and FDA labeling. Check back soon for approved therapeutic uses.
Clinical Trials (3)
Post-marketing Surveillance (PMS) Use-Result Surveillance With SPIKEVAX BIVALENT, SPIKEVAX X Injection, SPIKEVAX JN Injection and SPIKEVAX IN PRE-FILLED SYRINGE
Started Mar 2023
4,207 enrolled
SARS-CoV-2
Study to Assess Maternal and Infant Outcomes Following Exposure to SPIKEVAX During Pregnancy
Started Mar 2023
1,192 enrolled
Maternal OutcomesInfant OutcomesPregnancy
A Study to Assess Long-term Outcomes of Myocarditis Following Administration of COVID-19 mRNA Vaccine (SPIKEVAX)
Started Apr 2022
1,500 enrolled
Myocarditis
Career Relevance
Spikevax careers are concentrated in technical and operational roles—Manufacturing, Engineering, R&D, and Regulatory Affairs—reflecting vaccine production complexity and ongoing compliance demands. This product offers strong career growth potential in supply chain, process development, and quality assurance roles as the vaccine scales and adapts to new variants.
Worked on Spikevax at Moderna? Share your interview experience or compensation data (+7 days Pro)
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.